Stay updated with breaking news from டேவிட் பிரதான. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Artwork to be placed near Haddington | East Lothian Courier eastlothiancourier.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eastlothiancourier.com Daily Mail and Mail on Sunday newspapers.
诚益通:对深圳证券交易所《关于对北京诚益通控制工程科技股份有限公司的2020年年报问询函》之回复- CFi.CN 中财网 cfi.net.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cfi.net.cn Daily Mail and Mail on Sunday newspapers.
Addiction charity thanks Trainspotting cast for saving hundreds of lives Vital services were funded thanks to support from the cast of T2. 04:30, 25 FEB 2021 Trainspotting 2 cast (Image: Getty Images for Sony Pictures) Get the stories that matter to you sent straight to your inbox with our daily newsletter.Invalid EmailSomething went wrong, please try again later. Subscribe When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. OurPrivacy Noticeexplains more about how we use your data, and your rights. You can unsubscribe at any time. ....
Vancouver biotech Notch Therapeutics raises US$85-million in venture funding theglobeandmail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theglobeandmail.com Daily Mail and Mail on Sunday newspapers.
Published: Feb 10, 2021 VANCOUVER, BC, Feb. 10, 2021 /PRNewswire/ Notch Therapeutics, Inc., a biotechnology company developing renewable, induced pluripotent stem cell (iPSC)-derived cell therapies for cancer, announced today the closing of an oversubscribed U.S. $85 million Series A financing. The financing was led by an exclusively healthcare-focused investment fund, with participation by existing investors Allogene Therapeutics, Inc. (NASDAQ: ALLO), Lumira Ventures, and CCRM Enterprises Holdings Ltd., an affiliate of Centre for Commercialization of Regenerative Medicine (CCRM); along with new investors EcoR1 Capital, a undisclosed leading global investment firm, Casdin Capital, Samsara BioCapital, and Amplitude Ventures. Proceeds from the financing will support the continuing development of Notch s portfolio of iPSC-derived T cell therapeutic product candidates and clinical readiness of the company s proprietary Engineered Thymic Niche (ETN) platform. The finan ....